GlassScriptPhysician profile
Marc Adrian Caragea
NPI 1487158960
$4,784.86
in general payments reported to CMS, 2019-2025
22 companies · $1,226 in 2025
The $1,226 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $374 · 2023: $646 · 2024: $2,538 · 2025: $1,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,901 · Travel and Lodging: $1,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,900.96 |
| Travel and Lodging | $1,509.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,769.85 | 2022-2025 | General - Pain Management |
| Medtronic, INC. | $1,202.74 | 2024-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Nevro Corp. | $598.23 | 2023-2024 | Senza |
| Stryker Corporation | $349.67 | 2022-2025 | Spinejack, Multigen 2, Clottriever Bold Catheter |
| Spr Therapeutics, INC | $175.01 | 2022-2025 | Sprint Pns System |
| Inari Medical, INC. | $94.15 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stratus Medical, LLC | $75.70 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $72.63 | 2024-2025 | |
| Globus Medical, INC. | $68.81 | 2025 | Senza |
| Saluda Medical Americas, INC. | $48.49 | 2025 | Evoke |
| Bioventus LLC | $46.09 | 2023-2024 | Durolane, Durolane |
| Peerless Surgical INC. | $45.67 | 2024 | |
| Abbott Laboratories | $42.92 | 2023 | Octrode |
| Avanos Medical | $33.67 | 2024-2025 | Standard Rf Disposables, Generator |
| Abbvie INC. | $25.78 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $24.25 | 2023 | Zilretta, Iovera, Exparel |
| Vericel Corporation | $21.39 | 2025 | |
| Nalu Medical, INC. | $20.32 | 2025 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $19.39 | 2022 | |
| Curonix LLC | $19.05 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $18.44 | 2023 | Prolia, Evenity |
| Vertos Medical, INC. | $12.61 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Caragea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.